Exact Mass: 189.09357799999998
Exact Mass Matches: 189.09357799999998
Found 197 metabolites which its exact mass value is equals to given mass value 189.09357799999998,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Castanospermine
Castanospermine is a tetrahydroxyindolizidine alkaloid that consists of octahydroindolizine having four hydroxy substituents located at positions 1, 6, 7 and 8 (the 1S,6S,7R,8R,8aR-diastereomer). It has a role as a metabolite, an anti-HIV-1 agent, an anti-inflammatory agent and an EC 3.2.1.* (glycosidase) inhibitor. Castanospermine is a natural product found in Alexa grandiflora, Alexa wachenheimii, and other organisms with data available. A tetrahydroxyindolizidine alkaloid that consists of octahydroindolizine having four hydroxy substituents located at positions 1, 6, 7 and 8 (the 1S,6S,7R,8R,8aR-diastereomer). D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007004 - Hypoglycemic Agents > D065089 - Glycoside Hydrolase Inhibitors D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors KEIO_ID C043 Castanospermine inhibits all forms of α- and β-glucosidases, especially glucosidase L.
N-Nitrosoanatabine
C10H11N3O (189.09020759999999)
N-Lactoylvaline
N-Lactoylvaline is a lactoyl derivative of phenylalanine. N-Lactoyl-amino acids are ubiquitous pseudodipeptides of lactic acid and amino acids that are rapidly formed by reverse proteolysis. A protease, cytosolic nonspecific dipeptidase 2 (CNDP2), catalyzes their formation. The plasma levels of these metabolites strongly correlate with plasma levels of lactate and amino acid (PMID: 25964343).
N-Methylcalystegine B2
N-Methylcalystegine B2 is an alkaloid from the roots of Lycium chinense (Chinese boxthorn). Alkaloid from the roots of Lycium chinense (Chinese boxthorn)
1-hydroxyhexanoylglycine
1-Hydroxyhexanoylglycine is classified as a member of the Alpha amino acids. Alpha amino acids are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). 1-Hydroxyhexanoylglycine is considered to be soluble (in water) and acidic.ÂÂ
2-hydroxyhexanoylglycine
2-Hydroxyhexanoylglycine is classified as a member of the N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. 2-Hydroxyhexanoylglycine is considered to be slightly soluble (in water) and acidic.
3-hydroxyhexanoylglycine
3-Hydroxyhexanoylglycine is classified as a member of the N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. 3-Hydroxyhexanoylglycine is considered to be slightly soluble (in water) and acidic.
4-hydroxyhexanoylglycine
4-Hydroxyhexanoylglycine is classified as a member of the N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. 4-Hydroxyhexanoylglycine is considered to be slightly soluble (in water) and acidic.
5-hydroxyhexanoylglycine
5-Hydroxyhexanoylglycine is classified as a member of the N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. 5-Hydroxyhexanoylglycine is considered to be slightly soluble (in water) and acidic.
1-Carboxyethylvaline
1-Carboxyethylvaline belongs to the class of organic compounds known as valine and derivatives. These are compounds containing valine or a derivative thereof resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. 1-Carboxyethylvaline was identified as one of forty plasma metabolites that could be used to predict gut microbiome Shannon diversity (PMID: 31477923). Shannon diversity is a metric that summarizes both species abundance and evenness, and it has been suggested as a marker for microbiome health.
1-(2,7-dimethylpyrazolo[1,5-a]pyrimidin-6-yl)ethanone
C10H11N3O (189.09020759999999)
5-methyl-N-(pyridin-3-ylmethyl)isoxazol-3-amine
C10H11N3O (189.09020759999999)
1,2,3,4,7-Pentahydroxy-6-nitrobicyclo[3.3.0]octane
1,2-O-Isopropylidene-alpha-D-Furanose-3-Amino-3-deoxyribose
1H-Benzimidazole-2-propanamide(9CI)
C10H11N3O (189.09020759999999)
Cyclopentanecarboxylic acid, 4-amino-2,3-dihydroxy-, ethyl ester,
2-(3-(PYRIDIN-4-YL)-1H-PYRAZOL-1-YL)ETHANOL
C10H11N3O (189.09020759999999)
2-(4-aminophenyl)-3-methyl-1H-pyrazol-5-one
C10H11N3O (189.09020759999999)
3-AMINO-2-ETHYL-4(3H)-QUINAZOLINONE
C10H11N3O (189.09020759999999)
1-(4-METHOXY-PHENYL)-1H-PYRAZOL-3-YLAMINE
C10H11N3O (189.09020759999999)
2-(3-aminophenyl)-2,4-dihydro-5-methyl-3H-pyrazol-3-one
C10H11N3O (189.09020759999999)
2-(methylaminomethyl)-1H-quinazolin-4-one
C10H11N3O (189.09020759999999)
(5-Methyl-2-phenyl-2H-1,2,3-triazol-4-yl)methanol
C10H11N3O (189.09020759999999)
2-(4-Morpholinyl)Isonicotinonitrile
C10H11N3O (189.09020759999999)
4-(4-METHOXYPHENYL)-1H-PYRAZOL-3-AMINE
C10H11N3O (189.09020759999999)
N-{[(2-Methyl-2-Propanyl)Oxy]Carbonyl}-L-(1-13C)Alanine
(2-BENZHYDRYLOXYCARBONYLAMINO-6-OXO-1,6-DIHYDRO-PURIN-9-YL)-ACETICACID
C10H11N3O (189.09020759999999)
(1-BENZYL-1H-1,2,3-TRIAZOL-4-YL)METHANOL
C10H11N3O (189.09020759999999)
[2-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]METHANOL
C10H11N3O (189.09020759999999)
Pyrido[2,3-b]pyrazine-2,3-diamine, N,N-dimethyl- (9CI)
[4-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]METHANOL
C10H11N3O (189.09020759999999)
9-Azabicyclo[3.3.1]nonan-3-one,9-methyl-, hydrochloride (1:1)
5-(3-Methoxyphenyl)-1H-iMidazol-2-aMine
C10H11N3O (189.09020759999999)
5-(4-Methoxyphenyl)-1H-imidazol-2-amine
C10H11N3O (189.09020759999999)
Pyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-one, 6a,7,8,9-tetrahydro- (9CI)
C10H11N3O (189.09020759999999)
4-(5-ethyl-1,2,4-oxadiazol-3-yl)aniline
C10H11N3O (189.09020759999999)
5-(3-Methoxyphenyl)-2H-pyrazol-3-ylamine
C10H11N3O (189.09020759999999)
METHYL-(3-PHENYL-[1,2,4]OXADIAZOL-5-YLMETHYL)-AMINE
C10H11N3O (189.09020759999999)
C-(3-Benzyl-[1,2,4]oxadiazol-5-yl)-methylaminehydrochloride
C10H11N3O (189.09020759999999)
5-(2-Methoxy-phenyl)-1H-pyrazol-3-ylamine
C10H11N3O (189.09020759999999)
5-(2-Methoxyphenyl)-1H-pyrazol-3-amine
C10H11N3O (189.09020759999999)
4-amino-2-pyrrolidin-1-ylpyrimidine-5-carbonitrile
2-(4-AMINOMETHYL-OXAZOL-2-YL)-PHENYLAMINE
C10H11N3O (189.09020759999999)
1-ethyl-3-hydrazono-1,3-dihydro-indol-2-one
C10H11N3O (189.09020759999999)
1H-Imidazo[1,2-a]benzimidazole,2,3-dihydro-6-methoxy-(9CI)
C10H11N3O (189.09020759999999)
3H-Pyrazol-3-one,2-(4-aminophenyl)-2,4-dihydro-5-methyl-
C10H11N3O (189.09020759999999)
2-amino-2-cyano-n-p-toylyl-acetamide
C10H11N3O (189.09020759999999)
5-methoxy-1h-indole-3-carboxamidine
C10H11N3O (189.09020759999999)
1-METHYL-1H-INDOLE-3-CARBOHYDRAZIDE
C10H11N3O (189.09020759999999)
(5-benzyl-1,2,4-oxadiazol-3-yl)methanamine
C10H11N3O (189.09020759999999)
1-(4-METHOXYBENZYL)-1,2,4-TRIAZOLE
C10H11N3O (189.09020759999999)
3-(4-Methoxyphenyl)-1H-pyrazol-5-amine
C10H11N3O (189.09020759999999)
Pyrido[2,3-b]pyrazin-2(1H)-one, 3-(1-methylethyl)- (9CI)
C10H11N3O (189.09020759999999)
Pyrido[2,3-b]pyrazin-3(4H)-one, 2-(1-methylethyl)- (9CI)
C10H11N3O (189.09020759999999)
Pyrido[2,3-b]pyrazin-6(4H)-one, 3-amino-8-methyl- (9CI)
C10H11N3O (189.09020759999999)
(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methanamine
1H-Benzimidazole-2-acetamide,N-methyl-(9CI)
C10H11N3O (189.09020759999999)
2-(2-AMINOETHYL)QUINAZOLIN-4(3H)-ONE
C10H11N3O (189.09020759999999)
[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanamine
C10H11N3O (189.09020759999999)
[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methanamine
C10H11N3O (189.09020759999999)
1-(4-Methoxybenzyl)-1H-1,2,4-triazole
C10H11N3O (189.09020759999999)
Azolimine
C10H11N3O (189.09020759999999)
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49186 - Potassium-Sparing Diuretic
Pyrimido[1,2-a]benzimidazol-8-ol, 1,2,3,4-tetrahydro- (9CI)
C10H11N3O (189.09020759999999)
2-ISOPROPYL-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-6-CARBALDEHYDE
C10H11N3O (189.09020759999999)
Pyrido[2,3-b]pyrazin-3(4H)-one, 2,6,8-trimethyl- (9CI)
C10H11N3O (189.09020759999999)
1H-Benzimidazole-1-carboxamide,N,N-dimethyl-(9CI)
C10H11N3O (189.09020759999999)
1H-Benzimidazole-1-acetamide,2-methyl-(9CI)
C10H11N3O (189.09020759999999)
Pyrrolidine, 1-(2-chloro-1-oxopropyl)-2,2-dimethyl- (9CI)
methyl-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-amine
C10H11N3O (189.09020759999999)
1-isopropyl-1h-benzo[d][1,2,3]triazole-5-carbaldehyde
C10H11N3O (189.09020759999999)
4-(4-hydroxyphenyl)-5-methyl-1,3-hiazol-2-amine
C10H11N3O (189.09020759999999)
(5-METHYL-4,5-DIHYDRO-1H-PYRAZOL-1-YL)(PYRIDIN-3-YL)METHANONE
C10H11N3O (189.09020759999999)
2-(3-(pyridin-2-yl)-1H-pyrazol-1-yl)ethanol
C10H11N3O (189.09020759999999)
[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]METHANOL
C10H11N3O (189.09020759999999)
4-(4-AMINOMETHYL-OXAZOL-2-YL)-PHENYLAMINE
C10H11N3O (189.09020759999999)
4-methoxy-1h-indole-3-carboxamidine
C10H11N3O (189.09020759999999)
2-(3-PHENYL-[1,2,4]OXADIAZOL-5-YL)-ETHYLAMINE
C10H11N3O (189.09020759999999)
N,N-dimethyl-1H-indazole-3-carboxamide
C10H11N3O (189.09020759999999)
6-morpholin-4-ylpyridine-2-carbonitrile
C10H11N3O (189.09020759999999)
2-methyl-5-(1-methylpyrazol-4-yl)pyridin-3-ol
C10H11N3O (189.09020759999999)
9-Methyl-5,6,7,8-tetrahydrotetrazolo[5,1-b]quinazoline
3-Formyl-2-hydroxy-5-methyl-hexanoic acid hydroxyamide
2-{[Formyl(hydroxy)amino]methyl}-4-methylpentanoic acid
(2R)-2-{[Formyl(hydroxy)amino]methyl}hexanoic acid
(2S)-2-[[(1R)-1-carboxyethyl]amino]-3-methylbutanoic acid
(3R)-4-[dimethyl(trideuteriomethyl)azaniumyl]-3-formyloxybutanoate
N-[(3S,4R,5S)-4,5-dihydroxy-1-oxohexan-3-yl]acetamide
3-[(2R)-1-nitroso-3,4-dihydro-2H-pyridin-2-yl]pyridine
C10H11N3O (189.09020759999999)
(3S)-3-hydroxy-L-enduracididine(1+)
An alpha-amino-acid cation obtained by deprotonation of the carboxy group and protonation of the amino and guanidino groups of (3S)-3-hydroxy-L-enduracididine.
(1r,2r,3s,7s,7ar)-3-(hydroxymethyl)-hexahydro-1h-pyrrolizine-1,2,7-triol
(1s,2r,8r,8ar)-1,2,8-trihydroxy-octahydroindolizin-4-ium-4-olate
(1s,2r,3r,7s,7as)-3-(hydroxymethyl)-hexahydro-1h-pyrrolizine-1,2,7-triol
(1r,2r,3r,7r,7ar)-3-(hydroxymethyl)-hexahydro-1h-pyrrolizine-1,2,7-triol
(1s,2r,3r,7s,7ar)-3-(hydroxymethyl)-hexahydro-1h-pyrrolizine-1,2,7-triol
5-carboximidoyl-4-methoxy-1h,1'h-2,2'-bipyrrole
C10H11N3O (189.09020759999999)
3-(hydroxymethyl)-hexahydro-1h-pyrrolizine-1,2,7-triol
(1r,6r,7s,8s,8as)-octahydroindolizine-1,6,7,8-tetrol
(1r,6s,7s,8s,8as)-octahydroindolizine-1,6,7,8-tetrol
4-[2-(4,5-dihydro-3h-pyrrol-2-yl)hydrazin-1-ylidene]cyclohexa-2,5-dien-1-one
C10H11N3O (189.09020759999999)